Search

everythinglearnresearchcommunity

for

Search:↓

Visualizing data helps guide future androgenetic alopecia research and policies.

The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.

Continuous research and innovative strategies are essential for sustainable development.

Trichodynia is a painful scalp condition needing targeted treatments beyond symptom management.

The May 2021 issue of the Journal of Cosmetic Dermatology suggests injectables are becoming more reliable and may reduce the need for cosmetic surgery.

Newly found stem cells in horse hooves show promise for treating a hoof disease called laminitis.

Shi-Bi-Man activates hair follicle stem cells and promotes hair growth by changing lactic acid metabolism and other cellular processes.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Zinc is essential for plant growth and human health, but many soils lack enough zinc, affecting crops and potentially leading to health problems.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Mesenchymal stem cells could help treat aging-related diseases better than current methods.

The document lists various skin conditions and structures named "corona" that are not related to the coronavirus.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Cepharanthine helps reduce cell aging caused by the cancer drug Doxorubicin by boosting cell cleanup processes.

Baricitinib helps with severe hair loss, negative-pressure therapy lowers hernia recurrence, tranexamic acid reduces bleeding, robot-assisted breast surgery may improve outcomes, and acellular dermal matrix could decrease breast reconstruction complications.

Plasma therapy is becoming more popular for treating viral infections, skin conditions, and orthopedic issues, and is expected to grow in the healthcare market.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Metatrials could improve clinical research in nephrology by speeding up data collection and overcoming challenges like patient recruitment.

Stem cell therapy is promising for treating various health conditions, but more research is needed to understand its full potential and address challenges.

The new hydrogel treatment promotes faster hair growth and better skin health for hair loss.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Long COVID is more common in those with severe initial infections, but not linked to blood group.

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.

Convolvulus arvensis ethanolic extract can potentially promote hair growth and reduce hair loss.